UT Health San Antonio and partners secure NIH funding to translate scientific discoveries into therapeutic benefits

The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) and seven regional collaborators will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being.

ASCO 2024: FDA oncology head wants clinical trials to range beyond China alone

CHICAGO — The Food and Drug Administration’s top oncologist reiterated that the agency doesn’t want drugmakers applying for approval with data from trials solely run in

June 1, 2024

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.”

January 13, 2024

BioXcel stock craters after disclosure of investigator’s falsified safety report in Alzheimer’s study

BioXcel touted data Thursday morning claiming that Igalmi, its drug for agitation episodes, succeeded in a pivotal trial with Alzheimer’s patients, reducing a composite of

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.